Diagnostics News and Research

RSS

Researchers present new model for evaluating malaria treatment programs across multiple countries

In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries.

13 May 2015

MEDICA CONNECTED HEALTHCARE FORUM will continue being a programme highlight at the MEDICA IT area

After its widely acclaimed debut and high level of public appeal within the scope of the MEDICA 2014, the MEDICA CONNECTED HEALTHCARE FORUM is going to be continued this year and is going to remain an important highlight within the programme of the world’s largest medical trade fair, MEDICA, which most recently had around 4,800 exhibitors and almost 130,000 specialist visitors.

12 May 2015

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

The European Investment Bank (EIB), the world’s largest multilateral bank, today reaffirmed its firm commitment to respond to the Ebola pandemic. The Bank has provided a EUR 50 million loan to Bavarian Nordic, an international biopharmaceutical company, for accelerated development of an Ebola vaccine with long-term efficacy. The financing is also backing research into vaccines for treating other infectious diseases and multiple cancer indications.

12 May 2015

Novel insights into the genetics of autism

A study of 2,377 children with autism, their parents and siblings has revealed novel insights into the genetics of the condition.

12 May 2015

Preventice Solutions announces commercial availability of BodyGuardian Heart and PatientCare Platform

Preventice Solutions announced today that BodyGuardian Heart Remote Patient Monitoring System and PatientCare platform will be commercially available in Q3, 2015. Testing with the BodyGuardian Remote Monitoring System is underway nationally to ensure ongoing improvements and care team efficiency.

11 May 2015

Panacea Pharmaceuticals selects Goodwin to complete novel vaccine Fill / Finish project

Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.

11 May 2015

BHI awarded NIH contract to provide mentoring and training for NINDS grantees

BioHealth Innovation, Inc. is providing grantees of the National Institute of Health's National Institute of Neurological Disorders and Stroke with mentoring and training designed to develop and hone their presentation skills as a step toward securing investment dollars and strategic partners.

11 May 2015

New CLIP-PCR test could help diagnose malaria cases

One of the biggest difficulties faced by worldwide programs aimed at eliminating malaria is that the tests they use are not sensitive enough to detect all people who have the disease and need treatment.

11 May 2015

The Project Data Sphere® initiative achieves 1st year milestones

Cancer community broadly shares, integrates, and analyzes clinical trial data within a single research platform to advance innovation and improve lives...

11 May 2015

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

Over nearly 15 years spent studying ticks, Indiana University's Keith Clay has found southern Indiana to be an oasis free from Lyme disease, the condition most associated with these arachnids that are the second most common parasitic disease vector on Earth.

11 May 2015

The future of cancer treatment set to be transformed through the opening of new Cancer Institute

NHS patients will soon benefit from the opening of a new cancer centre specialising in the use of diagnostics for targeted cancer medicines used to treat some of the UK’s most common cancers...

11 May 2015

Roche announces FDA approval of cobas KRAS Mutation Test for diagnostic use

Roche today announced that the U.S. Food and Drug Administration has approved the cobas KRAS Mutation Test for diagnostic use. The real-time PCR test is designed to identify KRAS mutations in tumor samples from metastatic colorectal cancer (mCRC) patients and aid clinicians in determining a therapeutic path for them.

11 May 2015

New direct connectivity introduced for Proxima patient dedicated arterial blood gas analyser

The new enhancement ensures that all patient test data for blood gas and electrolyte measurements, as well as system quality control data, can be transferred via an Ethernet connection to the hospital information network...

7 May 2015

Quest Diagnostics launches genomic test service that aids in diagnosis for myeloid neoplasms

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced LeukoVantage, an evidence-based genomic test service that aids in the diagnosis, prognosis, monitoring and selection of treatment for myeloid neoplasms, a group of hematologic malignancies that includes acute myeloid leukemia (AML), the most common form of adult acute leukemia, as well as myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPNs).

From Quest Diagnostics 7 May 2015

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.

7 May 2015

EKF introduces specific biomarker test for early sepsis identification

EKF Diagnostics, the global diagnostics company, announces that it has introduced the Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay.

From EKF Diagnostics 7 May 2015

Medilink UK Awards - The Winners 2015

The best of the UK's Life Sciences and Healthcare Technology sector have been honoured at the 2015 Medilink UK Awards.

6 May 2015

NanoPass signs license agreement for supply of MicronJet600 device to Circassia

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for the supply of MicronJet600, its microneedle delivery device, to Circassia Pharmaceuticals plc. (Oxford, UK), a specialty biopharmaceutical company focused on the allergy market.

6 May 2015

Researchers compile new genomic interactions catalogue

New clues about diseases like inflammatory bowel disorder may be found thanks to a new genomic interactions catalogue by a group of researchers in Japan and the United Kingdom. This research will be published on May 4, 2015 in Nature Genetics.

6 May 2015

NEB announces issuance of US patent for RNA-seq technology

New England Biolabs, Inc. announces the issuance of United States Patent Number 8,999,677, which describes a novel method for retaining valuable strand-specific information contained within RNA transcripts.

From New England Biolabs 6 May 2015

Diagnostics News and Research

Researchers present new model for evaluating malaria treatment programs across multiple countries

MEDICA CONNECTED HEALTHCARE FORUM will continue being a programme highlight at the MEDICA IT area

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

Novel insights into the genetics of autism

Preventice Solutions announces commercial availability of BodyGuardian Heart and PatientCare Platform

Panacea Pharmaceuticals selects Goodwin to complete novel vaccine Fill / Finish project

BHI awarded NIH contract to provide mentoring and training for NINDS grantees

New CLIP-PCR test could help diagnose malaria cases

The Project Data Sphere® initiative achieves 1st year milestones

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

The future of cancer treatment set to be transformed through the opening of new Cancer Institute

Roche announces FDA approval of cobas KRAS Mutation Test for diagnostic use

New direct connectivity introduced for Proxima patient dedicated arterial blood gas analyser

Quest Diagnostics launches genomic test service that aids in diagnosis for myeloid neoplasms

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

EKF introduces specific biomarker test for early sepsis identification

Medilink UK Awards - The Winners 2015

NanoPass signs license agreement for supply of MicronJet600 device to Circassia

Researchers compile new genomic interactions catalogue

NEB announces issuance of US patent for RNA-seq technology

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News